Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> GILEAD SCIENCES Latest News

JUN 30, 2014 - Benzinga

A Must Read - Share

UPDATE: Morgan Stanley Reiterates On Gilead Sciences On EM Sovaldi

In a report published Monday, Morgan Stanley analyst Matthew Harrison reiterated an Equal-Weight rating on Gilead Sciences (NASDAQ: GILD), but removed the $75.00 price target.

Tags: UPDATE: Morgan Stanley Reiterates On Gilead Sciences On EM Sovaldi,  Gilead Sciences Latest News